Grove Nanomaterials Limited
Private Limited Company · Swansea
ActiveUnited KingdomIncorporated 2018Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · company scope
Net assets
−£49,987
Cash
£65,348
Turnover
—
Profit / loss
—
Current assets
£117,948
Creditors < 1 year
—
Equity
−£49,987
Average employees
5
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2025-12-31GBP · company | 2024-12-31GBP · company | 2024-03-31GBP · company | 2023-03-31GBP · unknown | 2022-03-31GBP · unknown | 2021-03-31GBP · unknown | 2020-03-31GBP · unknown | 2019-03-31GBP · unknown |
|---|---|---|---|---|---|---|---|---|
| Balance sheet | ||||||||
| Net assets | −£49,987 | −£22,674 | £140,503 | £65,651 | £100 | £100 | £100 | — |
| Equity | −£49,987 | −£22,674 | £140,503 | £65,651 | £100 | £100 | £100 | £100 |
| Assets | ||||||||
| Fixed assets | £71,668 | £65,833 | £15,445 | £0 | — | — | — | — |
| Intangible assets | £5,011 | £5,302 | £5,519 | £0 | — | — | — | — |
| Property, plant & equipment | £66,657 | £60,531 | £9,926 | £0 | — | — | — | — |
| Current assets | £117,948 | £101,917 | £260,327 | £71,651 | — | — | — | £100 |
| Cash at bank | £65,348 | £48,742 | £256,967 | £66,800 | £100 | £100 | £100 | — |
| Debtors | £52,600 | £53,175 | £3,360 | £4,851 | — | — | — | — |
| Liabilities | ||||||||
| Net current assets | £52,351 | £61,861 | £258,413 | £65,651 | — | — | — | £100 |
| Assets less current liabilities | £124,019 | £127,694 | £273,858 | £65,651 | — | — | — | — |
| People | ||||||||
| Average employees | 5 | 4 | — | — | — | — | — | 1 |
| Source evidence | View filing | View filing | View filing | View filing | View filing | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
3 outstanding chargesAll Assets · created 2024-03-21
—
OutstandingFixed · created 2024-03-21
—
OutstandingFixed · created 2024-03-21
—
Outstanding